| Effect | None |
| Trial Design | Cohort |
| Trial Length | 6+ Months |
| Number of Subjects | 25 |
| Sex | Both Genders |
| Age Range | 45-64 |
| Body Types | Obese |
Supplementation of 1,000µg chromium (as picolinate) alongside sulfonylurea therapy for 10 months in type II diabetic persons noted that, relative to a sulfonylurea/placebo pairing, that chromium resulted in an additional decrease in glucose and free fatty acids in serum without any other significant alterations.
There appeared to be an anti-obese effect of chromium, as the 0.9kg weight gain with sulfonylurea therapy was mitigated with chromium coingestion.
